Selected research
Industry Research
Azacitidine Injection Industry Research Report 2026
Market perspective
The global Azacitidine Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Azacitidine Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Azacitidine Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Azacitidine Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Azacitidine Injection include Accord Healthcare, Celgene, Dr. Reddy's Laboratories, Eurohealth, Natco Pharma, Shilpa Medicare, Hansoh Pharma, Huiyu Pharmaceutital and Mylan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Azacitidine Injection market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Azacitidine Injection Market by Company
Accord Healthcare
Celgene
Dr. Reddy's Laboratories
Eurohealth
Natco Pharma
Shilpa Medicare
Hansoh Pharma
Huiyu Pharmaceutital
Mylan
CTTQ
Azacitidine Injection Segment by Type
50mg
100mg
Azacitidine Injection Segment by Application
Chronic Myelomonocytic Leukemia (CMML)
Acute Myeloid Leukemia (AML)
Higher-risk myelodysplastic syndromes (MDS)
Others
Azacitidine Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Azacitidine Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Azacitidine Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Azacitidine Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Azacitidine Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Azacitidine Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Azacitidine Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 50mg
- 100mg
Applications
- Chronic Myelomonocytic Leukemia (CMML)
- Acute Myeloid Leukemia (AML)
- Higher-risk myelodysplastic syndromes (MDS)
- Others
Companies covered
- Accord Healthcare
- Celgene
- Dr. Reddy's Laboratories
- Eurohealth
- Natco Pharma
- Shilpa Medicare
- Hansoh Pharma
- Huiyu Pharmaceutital
- Mylan
- CTTQ
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Azacitidine Injection Market Size (2021-2032)
- 2.2.2 Global Azacitidine Injection Sales (2021-2032)
- 2.2.3 Global Azacitidine Injection Market Average Price (2021-2032)
- 2.3 Azacitidine Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 50mg
- 2.3.3 100mg
- 2.4 Azacitidine Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Chronic Myelomonocytic Leukemia (CMML)
- 2.4.3 Acute Myeloid Leukemia (AML)
- 2.4.4 Higher-risk myelodysplastic syndromes (MDS)
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Azacitidine Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Azacitidine Injection Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Azacitidine Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Azacitidine Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Azacitidine Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Azacitidine Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Azacitidine Injection, Product Type & Application
- 3.8 Global Manufacturers of Azacitidine Injection, Established Date
- 3.9 Global Azacitidine Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Accord Healthcare
- 4.1.1 Accord Healthcare Company Information
- 4.1.2 Accord Healthcare Business Overview
- 4.1.3 Accord Healthcare Azacitidine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Accord Healthcare Azacitidine Injection Product Portfolio
- 4.1.5 Accord Healthcare Recent Developments
- 4.2 Celgene
- 4.2.1 Celgene Company Information
- 4.2.2 Celgene Business Overview
- 4.2.3 Celgene Azacitidine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Celgene Azacitidine Injection Product Portfolio
- 4.2.5 Celgene Recent Developments
- 4.3 Dr. Reddy's Laboratories
- 4.3.1 Dr. Reddy's Laboratories Company Information
- 4.3.2 Dr. Reddy's Laboratories Business Overview
- 4.3.3 Dr. Reddy's Laboratories Azacitidine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Dr. Reddy's Laboratories Azacitidine Injection Product Portfolio
- 4.3.5 Dr. Reddy's Laboratories Recent Developments
- 4.4 Eurohealth
- 4.4.1 Eurohealth Company Information
- 4.4.2 Eurohealth Business Overview
- 4.4.3 Eurohealth Azacitidine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Eurohealth Azacitidine Injection Product Portfolio
- 4.4.5 Eurohealth Recent Developments
- 4.5 Natco Pharma
- 4.5.1 Natco Pharma Company Information
- 4.5.2 Natco Pharma Business Overview
- 4.5.3 Natco Pharma Azacitidine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Natco Pharma Azacitidine Injection Product Portfolio
- 4.5.5 Natco Pharma Recent Developments
- 4.6 Shilpa Medicare
- 4.6.1 Shilpa Medicare Company Information
- 4.6.2 Shilpa Medicare Business Overview
- 4.6.3 Shilpa Medicare Azacitidine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Shilpa Medicare Azacitidine Injection Product Portfolio
- 4.6.5 Shilpa Medicare Recent Developments
- 4.7 Hansoh Pharma
- 4.7.1 Hansoh Pharma Company Information
- 4.7.2 Hansoh Pharma Business Overview
- 4.7.3 Hansoh Pharma Azacitidine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Hansoh Pharma Azacitidine Injection Product Portfolio
- 4.7.5 Hansoh Pharma Recent Developments
- 4.8 Huiyu Pharmaceutital
- 4.8.1 Huiyu Pharmaceutital Company Information
- 4.8.2 Huiyu Pharmaceutital Business Overview
- 4.8.3 Huiyu Pharmaceutital Azacitidine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Huiyu Pharmaceutital Azacitidine Injection Product Portfolio
- 4.8.5 Huiyu Pharmaceutital Recent Developments
- 4.9 Mylan
- 4.9.1 Mylan Company Information
- 4.9.2 Mylan Business Overview
- 4.9.3 Mylan Azacitidine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Mylan Azacitidine Injection Product Portfolio
- 4.9.5 Mylan Recent Developments
- 4.10 CTTQ
- 4.10.1 CTTQ Company Information
- 4.10.2 CTTQ Business Overview
- 4.10.3 CTTQ Azacitidine Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 CTTQ Azacitidine Injection Product Portfolio
- 4.10.5 CTTQ Recent Developments
5 Global Azacitidine Injection Market Scenario by Region
- 5.1 Global Azacitidine Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Azacitidine Injection Sales by Region: 2021-2032
- 5.2.1 Global Azacitidine Injection Sales by Region: 2021-2026
- 5.2.2 Global Azacitidine Injection Sales by Region: 2027-2032
- 5.3 Global Azacitidine Injection Revenue by Region: 2021-2032
- 5.3.1 Global Azacitidine Injection Revenue by Region: 2021-2026
- 5.3.2 Global Azacitidine Injection Revenue by Region: 2027-2032
- 5.4 North America Azacitidine Injection Market Facts & Figures by Country
- 5.4.1 North America Azacitidine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Azacitidine Injection Sales by Country (2021-2032)
- 5.4.3 North America Azacitidine Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Azacitidine Injection Market Facts & Figures by Country
- 5.5.1 Europe Azacitidine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Azacitidine Injection Sales by Country (2021-2032)
- 5.5.3 Europe Azacitidine Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Azacitidine Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Azacitidine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Azacitidine Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Azacitidine Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Azacitidine Injection Market Facts & Figures by Country
- 5.7.1 South America Azacitidine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Azacitidine Injection Sales by Country (2021-2032)
- 5.7.3 South America Azacitidine Injection Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Azacitidine Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Azacitidine Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Azacitidine Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Azacitidine Injection Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Azacitidine Injection Sales by Type (2021-2032)
- 6.1.1 Global Azacitidine Injection Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Azacitidine Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Azacitidine Injection Revenue by Type (2021-2032)
- 6.2.1 Global Azacitidine Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Azacitidine Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Azacitidine Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Azacitidine Injection Sales by Application (2021-2032)
- 7.1.1 Global Azacitidine Injection Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Azacitidine Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Azacitidine Injection Revenue by Application (2021-2032)
- 7.2.1 Global Azacitidine Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Azacitidine Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Azacitidine Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Azacitidine Injection Value Chain Analysis
- 8.1.1 Azacitidine Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Azacitidine Injection Production Mode & Process
- 8.2 Azacitidine Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Azacitidine Injection Distributors
- 8.2.3 Azacitidine Injection Customers
9 Global Azacitidine Injection Analyzing Market Dynamics
- 9.1 Azacitidine Injection Industry Trends
- 9.2 Azacitidine Injection Industry Drivers
- 9.3 Azacitidine Injection Industry Opportunities and Challenges
- 9.4 Azacitidine Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst